Calculate Zantac/ranitidine cancer lawsuit settlements. NDMA contamination, stomach, bladder, liver cancer claims.
Calculate SettlementMDL 2924
MDL Number
April 2020
FDA Recall
75K+
Claims Filed
Ongoing
State Litigation
Primary cancer linked to NDMA
$750,000
potential value
Strongly linked to NDMA exposure
$650,000
potential value
Associated with prolonged use
$600,000
potential value
Under investigation
$500,000
potential value
Zantac (ranitidine) lawsuits allege the popular heartburn medication contained NDMA, a probable carcinogen, at unsafe levels. The FDA recalled all ranitidine products in April 2020 after testing showed NDMA levels increased with heat and storage time.
While the federal MDL 2924 faced significant setbacks when a judge excluded plaintiff expert witnesses, state court litigation continues. Manufacturers may face ongoing liability as cases proceed through various state courts.
Our calculator provides estimates based on similar pharmaceutical litigation. Consult an attorney for current case status and options.
Free estimate based on 2026 litigation data.
Start Free Calculator